NDC 61958-2901
remdesivir
Remdesivir
remdesivir is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is Remdesivir.
| Product ID | 61958-2901_2618c503-ad4f-4c39-9bba-cd1f92ec327d |
| NDC | 61958-2901 |
| Product Type | Human Prescription Drug |
| Proprietary Name | remdesivir |
| Generic Name | Remdesivir |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-05-01 |
| Marketing Category | UNAPPROVED DRUG OTHER / NDA |
| Application Number | NDA214787 |
| Labeler Name | Gilead Sciences, Inc. |
| Substance Name | REMDESIVIR |
| Active Ingredient Strength | 100 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |